Drug Type Fusion protein |
Synonyms Fas/IL-2R agonists (Fascure Therapeutics) |
Target |
Action stimulants, agonists |
Mechanism FasR stimulants(Apoptosis-mediating surface antigen FAS stimulants), IL-2R agonists(Interleukin-2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Preclinical | United States | - |